The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Asthma Therapy
Arsenic Trioxide - Histamine Dihydrochloride - Dermatophagoides Pteronyssinus - Magnesium Phosphate, Dibasic Trihydrate - Strychnos Nux-Vomica Seed - Aspidosperma Quebracho-Blanco Bark - Suplhur - · STRYCHNOS NUX-VOMICA SEED 6 [hp_C]/1; ASPIDOSPERMA QUEBRACHO-BLANCO BARK 6 [hp_C]/1; SULFUR 6 [hp_C]/1; ARSENIC TRIOXIDE 6 [hp_C]/1; HISTAMINE DIHYDROCHLORIDE 6 [hp_C]/1; DERMATOPHAGOIDES PTERONYSSINUS 6 [hp_C]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_C]/1 · Tablet, Orally Disintegrating · Oral · TRP Company
NDC 17312-0017-14 · 1 BOTTLE in 1 PACKAGE / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Arsenic Trioxide - Histamine Dihydrochloride - Dermatophagoides Pteronyssinus - Magnesium Phosphate, Dibasic Trihydrate - Strychnos Nux-Vomica Seed - Aspidosperma Quebracho-Blanco Bark - Suplhur - (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| TRP Company | STRYCHNOS NUX-VOMICA SEED 6 [hp_C]/1; ASPIDOSPERMA QUEBRACHO-BLANCO BARK 6 [hp_C]/1; SULFUR 6 [hp_C]/1; ARSENIC TRIOXIDE 6 [hp_C]/1; HISTAMINE DIHYDROCHLORIDE 6 [hp_C]/1; DERMATOPHAGOIDES PTERONYSSINUS 6 [hp_C]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_C]/1 | Jul 22, 2026 | Sep 2, 2026 |
| TRP Company | ARSENIC TRIOXIDE 6 [hp_C]/1; ASPIDOSPERMA QUEBRACHO-BLANCO BARK 6 [hp_C]/1; DERMATOPHAGOIDES PTERONYSSINUS 6 [hp_C]/1; HISTAMINE DIHYDROCHLORIDE 6 [hp_C]/1; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_C]/1; STRYCHNOS NUX-VOMICA SEED 6 [hp_C]/1; SULFUR 6 [hp_C]/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Asthma Therapy — NDC 17312-0017-14," retrieved September 3, 2026, https://drugdashboards.com/drug/17312001714.
Free to cite with attribution — see how the data is put together.